Trade AbbVie ^ABBV

Securian Asset Management Inc. Sells 7,037 Shares of AbbVie Inc. $ABBV - Markets Daily

KLP Kapitalforvaltning AS Has $172.38 Million Stake in AbbVie Inc. $ABBV - Markets Daily

AbbVie Inc. $ABBV Stake Boosted by Park Avenue Securities LLC

AbbVie Inc. $ABBV Shares Purchased by KLP Kapitalforvaltning AS

Sivik Global Healthcare LLC Takes Position in AbbVie Inc. $ABBV

Assessing AbbVie (ABBV) Valuation After Recent Share Price Gain And Mixed Return Profile

AbbVie Inc. $ABBV Shares Acquired by Cerity Partners LLC

AbbVie Inc. $ABBV Stock Holdings Increased by Capital & Planning LLC

Alnuctamab, a bivalent B-cell maturation antigen-targeting T cell engager for patients with relapsed or refractory multiple myeloma: results from a phase 1, first-in-human study

Molecular and functional characterization of the B-cell receptor in chronic lymphocytic leukemia-like monoclonal B-cell lymphocytosis

AbbVie (NYSE:ABBV) Stock Price Up 1.7% - Still a Buy?

AbbVie Inc. $ABBV Shares Bought by Spirepoint Private Client LLC

Greenleaf Trust Sells 28,666 Shares of AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Holdings Lifted by Torray Investment Partners LLC

MAVIRET® receives Health Canada Approval for the Treatment of Acute Hepatitis C Virus

AbbVie Inc. $ABBV Shares Purchased by Sitrin Capital Management LLC

Will AbbVie's (ABBV) Zelgen Lung Cancer Deal Reshape Its Post‑Humira Resilience Narrative?

Torray Investment Partners LLC Has $23.53 Million Stake in AbbVie Inc. $ABBV - Stock Observer

Geneos Wealth Management Inc. Cuts Holdings in AbbVie Inc. $ABBV - Stock Observer

AbbVie (NYSE:ABBV) Stock Price Down 3.8% - Time to Sell?

Promising Pharmaceutical Stocks To Follow Now - January 5th - Markets Daily

Assessing AbbVie (ABBV) Valuation After Strong Multi‑Year Shareholder Returns

Railway Pension Investments Ltd Raises Holdings in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Holdings Raised by CWA Asset Management Group LLC

Commonwealth Equity Services LLC Cuts Holdings in AbbVie Inc. $ABBV

Asset Management One Co. Ltd. Raises Holdings in AbbVie Inc. $ABBV

Is AbbVie (ABBV) Still Attractively Priced After A 31.8% One Year Gain?

AbbVie Inc. $ABBV Holdings Lifted by Capital Advisors Inc. OK

Davis Capital Management Purchases New Stake in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Acquired by Gateway Investment Advisers LLC - Stock Observer

AbbVie (NYSE:ABBV) Downgraded by Wall Street Zen to Buy - Daily Political

Analysts' Downgrades for January 3rd (ABBV, ACAD, ACLS, AFRM, ARI, ARLP, AROW, ASAN, ASB, AUGO) - Markets Daily

Pharmaceutical Stocks To Keep An Eye On - January 3rd - Stock Observer

PICTET BANK & TRUST Ltd Invests $1.61 Million in AbbVie Inc. $ABBV

First Pacific Financial Increases Stock Holdings in AbbVie Inc. $ABBV

SteelPeak Wealth LLC Has $5.98 Million Position in AbbVie Inc. $ABBV

Bell Bank Sells 10,943 Shares of AbbVie Inc. $ABBV

Altfest L J & Co. Inc. Has $5.90 Million Stake in AbbVie Inc. $ABBV

First Pacific Financial Boosts Stock Holdings in AbbVie Inc. $ABBV - Stock Observer

AbbVie (NYSE:ABBV) Downgraded to "Buy" Rating by Wall Street Zen

Ironwood Reaffirms FY2025 Revenue Outlook, Sees Growth In FY2026; Stock Surges

Spotlight on Health ETFs as NVO & LLY Cut Obesity Drug Price in China

Hofer & Associates. Inc Purchases New Position in AbbVie Inc. $ABBV - Markets Daily

- Expects full-year 2026 LINZESS® U.S. net sales of $1.125 t

AbbVie Inc. (NYSE:ABBV) Receives Average Recommendation of "Moderate Buy" from Analysts - Markets Daily

New year sees Abbvie, Zelgen in $1.1B T-cell engager deal | BioWorld

Miracle Mile Advisors LLC Grows Position in AbbVie Inc. $ABBV - Markets Daily

Nicholas Wealth LLC. Cuts Stock Holdings in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Bought by Los Angeles Capital Management LLC

Miracle Mile Advisors LLC Has $13.65 Million Stock Position in AbbVie Inc. $ABBV - Stock Observer

Nicholas Wealth LLC. Decreases Holdings in AbbVie Inc. $ABBV - Daily Political

Shum Financial Group Inc. Purchases Shares of 5,336 AbbVie Inc. $ABBV - Daily Political

AbbVie (ABBV) Maintains Immunology Dominance as Analysts Downplay Competitive Threat From J&J's Tremfya to Skyrizi Market Share

VIRGINIA RETIREMENT SYSTEMS ET Al Grows Stake in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Acquired by Smith Salley Wealth Management

AbbVie Inc. $ABBV Shares Purchased by Brendel Financial Advisors LLC

Diversified Trust Co Purchases 10,891 Shares of AbbVie Inc. $ABBV

Ascent Group LLC Has $7.47 Million Holdings in AbbVie Inc. $ABBV

BofA Cuts AbbVie (ABBV) Target While Maintaining Neutral View

Sowell Financial Services LLC Sells 8,716 Shares of AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Sold by Sapient Capital LLC

AbbVie (NYSE:ABBV) - Stock Analysis - Simply Wall St

AbbVie Inc. (NYSE:ABBV) Given Average Recommendation of "Moderate Buy" by Brokerages

Meyer Handelman Co. Has $39.35 Million Stake in AbbVie Inc. $ABBV - Stock Observer

AbbVie Inc. $ABBV Shares Sold by Highland Capital Management LLC

5,829 Shares in AbbVie Inc. $ABBV Bought by Regent Peak Wealth Advisors LLC

Feasibility of outpatient administration of ciltacabtagene autoleucel and reduction in healthcare utilization cost: the Vanderbilt experience

World Investment Advisors Increases Position in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Sold by Pacer Advisors Inc.

Cwm LLC Has $87.91 Million Position in AbbVie Inc. $ABBV

Recent Research Analysts' Ratings Updates for AbbVie (ABBV) - Markets Daily

AbbVie Inc. $ABBV Shares Purchased by Brookstone Capital Management

Has AbbVie's 2025 Surge Already Priced In Its Expanding Immunology and Oncology Pipeline?

Welch Group LLC Purchases 3,149 Shares of AbbVie Inc. $ABBV - Markets Daily

AbbVie Inc. $ABBV Shares Sold by Yousif Capital Management LLC

Net Worth Advisory Group Has $886,000 Stake in AbbVie Inc. $ABBV - Markets Daily

Trust Co. of Vermont Buys 12,456 Shares of AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Sold by Exchange Traded Concepts LLC

AbbVie Inc. $ABBV Shares Acquired by Anderson Hoagland & Co.

Net Worth Advisory Group Has $886,000 Stake in AbbVie Inc. $ABBV - Stock Observer

AbbVie Inc. $ABBV Shares Acquired by Trust Co. of Vermont - Stock Observer

AbbVie, Neurocrine End One Orilissa Patent Case Against Hetero

3 Stocks Estimated To Be Trading Below Fair Value By Up To 46%

HBK Sorce Advisory LLC Grows Position in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Bought by Goelzer Investment Management Inc.

MediaPost Publications - Marketing Daily 12/23/2025

AbbVie Streams CLL Leukemia Awareness Film 12/23/2025

What AbbVie (ABBV)'s Restructured OSE Immunology Partnership Means For Shareholders

3 Dividend Growth Stocks Analysts Are Upgrading for 2026 | Investing.com

11,477 Shares in AbbVie Inc. $ABBV Purchased by Corsicana & Co. - Insurance News | InsuranceNewsNet

AbbVie Inc. $ABBV is CHICAGO TRUST Co NA's 8th Largest Position

Does OSE's ABBV-230 Shift Reveal a Deeper Risk-Sharing Strategy in AbbVie's Immunology Pipeline (ABBV)?

Vagus nerve-mediated neuroimmune modulation for rheumatoid arthritis: a pivotal randomized controlled trial

Top Medical Stocks To Follow Today - December 21st - Markets Daily

ABBV: Future Returns Will Hinge On Post-Humira Immunology And Pipeline Execution